BC Platforms AG has announced that it has partnered with Medaffcon Oy, a company specialized in generating Real World Evidence for health-related decision-making. The partnership focuses on harmonizing complex genomic and clinical data from multiple sources applying joint specialist knowledge and technological capabilities.
BC Platforms, founded in 1997 from an MIT Whitehead project spin-off, is in the business of powerful genomic data management and analysis solutions. The company operates a Global Network of Biobanks known as BCRQUEST.COM, a streamlined solution for secure data sharing, analytics and governance, enabling greater collaboration for scientific innovation.
BC Platforms has global operations with its headquarters in Basel, Switzerland, research and development in Helsinki, Finland, and sales and marketing in London, Boston, and Vancouver. The company’s vision is to build the world’s leading analytics platform for healthcare and industry by 2020.
Founded in 2009, based in Espoo, Finland, Medaffcon provides medical, scientific and market access services to international pharmaceutical and biotechnology industries as well as health-care operators. Known for its strong expertise in impact assessment, the company is actively developing research based on health data and measures that can be utilized in such research.
Constant improvement is reflected in the construction of a wide-ranging cooperation network with different actors in the health-care sector, in particular with regard to health data. Biobanks, registers and hospitals’ datapools enable entirely new kinds of studies and transform the field of impact assessment. Medaffcon is owned by the PHOENIX group, a large integrated European Healthcare provider ensuring that patients and the public have access to high-quality healthcare across Europe.
“We are very excited to be partnering with BC Platforms and their world leading network of biobanks through their BCRQUEST service. The collaboration will expand our capabilities of accessing and combining different Finnish and international data sources to advance research.” – Jaana Ahlamaa, Medical and Market Access Director at Medaffcon
“We are delighted to partner with Medaffcon, part of the PHOENIX group. Our goal is to combine our global platform to leverage Medaffcon´s extensive expertise in key markets in order to utilize Real World Evidence faster and more effectively.” – Tero Silvola, CEO of BC Platforms